Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05226260 · ClinicalTrials.gov registry record · NA
Decreasing Antibiotic Duration for Skin and Soft Tissue Infection Using Behavioral Economics in Primary Care
A NA study of Abscess and Cellulitis, sponsored by Nationwide Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 1,634
- Enrollment target
- 1
- Study location
NCT05226260 is a NA study of Abscess and Cellulitis that has completed, run by Nationwide Children's Hospital. The registered enrollment target is 1,634 participants, above the 264-participant average among 13 other Abscess trials with a reported enrollment target (519% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05226260, a NA study of Abscess and Cellulitis, has completed, sponsored by Nationwide Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,634 participants
- Enrollment target
- 1
- Study location
Study Summary
Study the efficacy of a package of behavioral economics strategies (versus an education-only control condition) in altering clinician behavior regarding antibiotic prescription duration for skin and soft tissue infection (SSTI).
Conditions Studied
Interventions
- BEHAVIORAL Default Duration order Panel
Study Locations (1)
Ohio
- Nationwide Children's Hospital Primary Care Clinics - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,634 participants |
| Start Date | 2021-11-01 |
| Est. Completion | 2025-01-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05226260
The ClinicalTrials.gov registry entry for NCT05226260 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,634 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 264-participant average among 13 other Abscess trials with a reported enrollment target (519% higher). The listed sponsor is Nationwide Children's Hospital, which has 188 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Abscess appearing as the primary indexed condition, and to 1 intervention - of which Default Duration order Panel is the first listed.
NCT05226260 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT05226260 about?
NCT05226260 is a clinical study titled "Decreasing Antibiotic Duration for Skin and Soft Tissue Infection Using Behavioral Economics in Primary Care". Study the efficacy of a package of behavioral economics strategies (versus an education-only control condition) in altering clinician behavior regarding antibiotic prescription duration for skin and soft tissue infection (SSTI).
What is the current status of trial NCT05226260?
This trial is currently completed. It is a NA study. The enrollment target is 1,634 participants. The study started on 2021-11-01. Estimated completion is 2025-01-20.
What conditions does trial NCT05226260 study?
This clinical trial studies the following conditions: Abscess, Cellulitis, Behavioral Economics, Impetigo, Skin Infection.
What interventions are being tested in trial NCT05226260?
The interventions under investigation include: Default Duration order Panel (BEHAVIORAL).
Who is sponsoring clinical trial NCT05226260?
This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05226260 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Abscess
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Adjunctive Nitrous Oxide During Emergency Department Propofol Sedation in Adults
COMPLETED · NA
-
Evaluation of 3 Versus 10 Days of Antibiotics in Skin Abscesses After Surgical Drainage
COMPLETED · NA
-
Ketamine as a Supplement to Local Anesthesia for Minor Procedures
RECRUITING · Phase 4
-
Efficacy of Intranasal Fentanyl at Reducing Pain During Abscess Incision and Drainage (I&D) in Children
COMPLETED · Phase 3
-
Aquacel Versus Iodoform Gauze for Filling Abscess Cavity Following Incision and Drainage
COMPLETED · Phase 2
-
Management of Skin and Soft Tissue Abscesses in Pediatric Patients After Incision and Drainage
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.